Project Grant K23DA063773
- Federal Grant Award Summary Friends Research Institute, Inc. received a $448,565 Project Grant from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) effective April 1, 2026, through March 31, 2027. The award supports a randomized controlled trial of Supporting Treatment for Opioids and Recovery Capital (STORC), a patient navigation intervention designed to enhance recovery outcomes for postpartum women with opioid use disorder (OUD)....
- Federal Grant Award Summary Rhode Island Hospital has received a $764,165 Project Grant from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) to develop and evaluate the CONNECT program, a digital intervention designed to increase engagement in HIV and substance use disorder care among survivors of sex trafficking. The award, effective July 1, 2025 through June 30, 2028, supports the development of an evidence-based intervention that...
- Federal Grant Award Summary Brown University received a $320,184 Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), effective July 1, 2026 through August 31, 2028. This K99/R00 career development award supports the co-development and preliminary testing of a brief intervention tailored to young adults (aged 18-25) with opioid use disorder (OUD) who have prematurely discontinued treatment. The research addresses a...
- Federal Grant Award Summary Rhode Island Hospital, a division of Lifespan Corporation, received a $859,962 Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), effective August 1, 2025, through April 30, 2028. The award supports the development and preliminary testing of a nurse-led, same-day HIV pre-exposure prophylaxis (PrEP) initiation intervention designed for incarcerated individuals with continuation of...
- Federal Grant Award Summary The University of Maryland, College Park received a $107,386 Project Grant from the National Institute on Drug Abuse under the Drug Use and Addiction Research Programs (CFDA 93.279) to develop a single-session, peer-delivered internalized stigma reduction intervention for individuals with polysubstance use in rural Maryland. The project, which commenced on May 15, 2026 and concludes on April 30, 2028, addresses a critical gap in substance use disorder (SUD)...
- Federal Grant Award Summary Brown University received a $159,500 Project Grant from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) awarded on May 15, 2026, with completion targeted for April 30, 2028. The research project investigates how drug use network influences affect overdose prevention program utilization among people who use unregulated drugs in Rhode Island. Nested within an ongoing evaluation of Rhode Island's first overdose...
- Federal Grant Award Summary Rutgers The State University of New Jersey, School of Nursing, received a $431,750 Project Grant from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) awarded July 1, 2025, with completion targeted for June 30, 2027. This research project will conduct a multi-method investigation into premium cigar use patterns and marketing exposure to address significant gaps in evidence regarding public health impacts. The...
- Federal Project Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded University of Colorado-Denver a $709,085 Project Grant effective April 1, 2026, through January 31, 2031, under the Drug Use and Addiction Research Programs (CFDA 93.279). This implementation trial will develop and test a facilitation intervention to increase in-hospital opioid treatment program (OTP) intake completion among hospitalized patients with opioid use disorder (OUD). The study employs a novel...
- Federal Grant Award Summary Rutgers The State University of New Jersey, School of Nursing received a $2.1 million Project Grant from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) to conduct a mixed-methods longitudinal study examining nicotine pouch adoption and use patterns among U.S. adults. The project, awarded September 15, 2025, with completion targeted for May 31, 2028, will employ a nationally representative longitudinal...
- Federal Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded the University of Massachusetts Medical School a $1.74 million Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) beginning July 15, 2025, with completion targeted for March 31, 2030. This award supports research focused on the discovery and functional characterization of long non-coding RNAs (lncRNAs) in opioid use disorder (OUD) within the context of HIV at single-cell resolution. The...
The University of Rhode Island received a $186,622 Project Grant from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) to develop and pilot the Stigma-Reduction Training and Addiction Resources for Registered Nurses (STAR-RN) intervention. Awarded on June 15, 2026, with a completion date of May 31, 2031, this project addresses the critical gap in pain management care for individuals with opioid use disorder (OUD) by targeting stigma among hospital-based nurses. The intervention will be co-developed using intervention mapping and community-based participatory research approaches, incorporating input from individuals with lived experience of OUD and bedside nurses to ensure clinical relevance and practical applicability. The project delivers two primary products: (1) the development of an evidence- and theory-informed STAR-RN intervention in a digital, modular format designed specifically for hospital-based nurses, and (2) a pilot study evaluating the intervention's feasibility, acceptability, and preliminary effectiveness in reducing nurse stigma, improving pain-related knowledge, and enhancing pain management self-efficacy. The STAR-RN intervention is designed to be scalable and adaptable, addressing a previously under-targeted workforce within broader opioid use disorder treatment efforts and directly aligning with NIDA's priorities in implementing evidence-based approaches for improved health outcomes in individuals with substance use disorders.Federal Project Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $186.6k | 6/4/26 |